General Information
|
|
Product
|
Podoplanin Peptide
|
Verified Applications
|
Immunodepletion, Immunocompetition
|
Peptide Description
|
Synthetic peptide taken within amino acid region 80-130 on human Podoplanin protein.
|
Physical Properties
|
|
Quantity
|
250 µg
|
Volume
|
100 µl
|
Form
|
Antigenic Blocking Peptide
|
Determinant
|
C-epitope
|
Storage
|
-20⁰C for long term storage
|
Application Protocol
|
Competition/Depletion assay
|
Refer to competition assay protocol
|
Protein
|
Uniprot #
|
Q86YL7
|
Overview
|
Invovled in cell migration and actin cytoskeleton organization. Induces changes in cell morphology with transfected cells showing an elongated shape, numerous membrane protusions, major reorganization of the actin cytoskeleton, increased motility and decreased cell adhesion when expressed in keratinocytes.
|
Molecular Function
|
Sialic acid; cell shape; developmental protein
|
Subcellular Location
|
Cell membrane; Cell projection
|
Expression
|
Placenta, lung, skeletal muscle and brain. Weakly expressed in brain kidney and liver.
|
Structure
|
Belongs to podoplanin family
|
Alternative Nomenclature
|
AGGRUS antibody
GLYCOPROTEIN 36 KD antibody
Glycoprotein 36 antibody
gp 36 antibody
GP 38 antibody
GP 40 antibody
HT1A 1 antibody
hT1alpha1 antibody
hT1alpha2 antibody
Lung type I cell membrane associated glycoprotein antibody
OTS8 antibody
PA2.26 antibody
PDPN antibody
Podoplanin antibody
PSEC0003 antibody
PSEC0025 antibody
T1 alpha antibody
TIA2 antibody
|
|
|